Quantitative Real-Time PCR in Cancer Research

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 5, 2003, Pages 301-313

  Mocellin, Simone ^b   Rossi, Carlo R ^b   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

Cancer research; Quantitative PCR

Indexed keywords

ACCURACY; ANALYTIC METHOD; BIOTECHNOLOGY; CANCER RESEARCH; GENE EXPRESSION; MEASUREMENT; MEDICAL INSTRUMENTATION; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR IMMUNOLOGY;

ANIMALS; HUMANS; NEOPLASM, RESIDUAL; NEOPLASMS; POLYMERASE CHAIN REACTION; RESEARCH;

EID: 0242656223     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. ABBASZADEGAN M. R., STRUEWING J. P., BROWN K. M., SNIDER J. V., GOODSAID F., GORE-LANGTON R. and HUGHES M. R. (1997): Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay. Genet. Test., 1, 171-180,
2. AERTS J., WYNENDAELE W., PARIDAENS R., CHRISTIAENS M. R., VAN DEN BOGAERT W., VAN OOSTEROM A. T. and VANDEKERCKHOVE F. (2001): A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann. Oncol., 12, 39-46.
3. ALTMAN J. D., MOSS P. A., GOULDER P. J., BAROUCH D. H., MCHEYZER-WILLIAMS M. G., BELL J. I., MCMICHAEL A. J. and DAVIS M. M. (1996): Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 94-96.
4. AMABILE M., GIANNINI B., TESTONI N., MONTEFUSCO V., ROSTI G., ZARDINI C., TERRAGNA C., BUONAMICI S., OTTAVIANI E., SOVERINI S., FIACCHINI M., BASSI S., DE VIVO A., TRABACCHI E., SAGLIO G., PANE F., BACCARANI M., TURA S. and MARTINELLI G. (2001): Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia, Haematologica, 86, 252-259,
5. BARTHE C., MAHON F. X., GHARBI M. J., FABERES C., BILHOU-NABERA C., HOCHHAUS A., REIFFERS J, and MARIT G, (2001): Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α-treated chronic myeloid leukemia. Blood, 97, 3568-2573.
6. BHATIA P., TAYLOR W. R., GREENBERG A. H. and WRIGHT J. A. (1994): Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Anal. Biochem., 216, 223-226.
7. BOLUFER P., LO COCO F., GRIMWADE D., BARRAGAN E., DIVERIO D., CASSINAT B., CHOMIENNE C., GONZALEZ M., COLOMER D., GOMEZ M. T., MARUGAN I., ROMAN J., DELGADO M. D., GARCIA-MARCO J. A., BORNSTEIN R., VIZMANOS J. L., MARTINEZ B., JANSEN J., VILLEGAS A., DE BLAS J. M., CABELLO P. and SANZ M. A. (2001): Variability in the levels of PML-RARα fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols. Haematologica, 86, 570-576.
8. BOSMA A. J., WEIGELT B., LAMBRECHTS A. C., VERHAGEN O. J., PRUNTEL R., HART A. A., RODENHUIS S. and VAN 'T VEER L. J. (2002): Detection of circulating breast tumor cells by differential expression of marker genes. Clin. Cancer Res., 8, 1871-1877.
9. BOULAY J. L., MILD G., LOWY A., REUTER J., LAGRANGE M., TERRACCIANO L., LAFFER U., HERRMANN R. and ROCHLITZ C. (2002): SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br. J, Cancer, 87, 630-634.
10. BOURAS T. and FRAUMAN A. G. (1999): Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. J. Pathol., 188, 382-388.
11. BUSTIN S. A. (2000): Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol., 25, 169-193.
12. BUSTIN S. A. and DORUDI S. (1998): Molecular assessment of tumour stage and disease recurrence using PCR-based assays. Mol. Med. Today, 4, 389-396.
13. BUSTIN S. A., GYSELMAN V. G., WILLIAMS N. S. and DORUDI S, (1999): Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br. J. Cancer, 79, 1813-1820.
14. BUSTIN S. A., LI, S. R., PHILLIPS S. and DORUDI S. (2001): Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of microsatellite-instability-positive tumours. Tumour Biol., 22, 294-298.
15. CALOGERO A., TIMMER-BOSSCHA H., SCHRAFFORDT KOOPS H., TIEBOSCH A. T., MULDER N. H. and HOSPERS G. A. (2000): Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. Br. J. Cancer, 83, 184-187.
16. CHAN A. T., LO Y. M., ZEE B., CHAN L. Y., MA B. B., LEUNG S. F., MO F., LAI M., HO S., HUANG D. P. and JOHNSON P. J. (2002): Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J. Natl. Cancer Inst., 94, 1614-1619.
17. CHELLY J., CONCORDET J. P., KAPLAN J. C. and KAHN A. (1989): Illegitimate transcription: transcription of any gene in any cell type. Proc. Natl. Acad. Sci. USA, 86, 2617-2621.
18. CHIANG P. W., SONG W. J., WU K. Y., KORENBERG J. R., FOGEL E. J., VAN KEUREN M. L., LASHKARI D. and KURNIT D. M. (1996): Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance. Genome Res., 6, 1013-1026.
19. COHEN C. D., FRACH K., SCHLONDORFF D. and KRETZLER M. (2002): Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int., 61, 133-140.
20. D'CUNHA J., CORFITS A. L., HERNDON J. E. 2nd, KERN J. A., KOHMAN L. J., PATTERSON G. A., KRATZKE R. A. and MADDAUS M. A. (2002): Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer - preliminary results of Cancer and Leukemia Group B Trial 9761. J. Thorac. Cardiovasc. Surg., 123, 484-491, discussion 491.
21. DE ARRUDA M., LYAMICHEV V. I., EIS P. S., ISZCZYSZYN W., KWIATKOWSKI R. W., LAW S. M., OLSON M. C. and RASMUSSEN E. B. (2002): Invader technology for DNA and RNA analysis: principles and applications. Expert. Rev. Mol. Diagn., 2, 487-496.
22. De CREMOUX P., EXTRA J. M., DENIS M. G., PIERGA J. Y., BOURSTYN E., NOS C., CLOUGH K. B., BOUDOU E., MARTIN E. C., MULLER A., POUILLART P. and MAGDELENAT H. (2000): Detection of MUCl-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin. Cancer Res., 6, 3117-3122.
23. DENG G., LU Y., ZLOTNIKOV G., THOR A. D. and SMITH H. S. (1996): Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science, 274, 2057-2059.
24. DESIRE N., DEHEE A., SCHNEIDER V., JACOMET C., GOUJON C., GIRARD P. M., ROZENBAUM W. and NICOLAS J. C. (2001): Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol., 39, 1303-1310.
25. DE VRIES T. J., FOURKOUR A., PUNT C. J., VAN DE LOCHT L. T., WOBBES T., VAN DEN BOSCH S., DE ROOIJ M. J., MENSINK E. J., RUITER D. J. and VAN MUIJEN G. N. (1999): Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br. J. Cancer, 80, 883-891.
26. DREXLER H. G., BORKHARDT A. and JANSSEN J. W. (1995): Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk. Lymphoma, 19, 359-380.
27. DUMOULIN F. L., NISCHALKE H. D., LEIFELD L., VON DEM BUSSCHE A., ROCKSTROH J. K., SAUERBRUCH T. and SPENGLER U. (2000): Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J. Immunol. Methods, 241, 109-119.
28. ELMAAGACLI A. H., BEELEN D. W., OPALKA B., SEEBER S. and SCHAEFER U. W. (2000): The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage. Ann. Hematol., 79, 424-431.
29. EMMERT-BUCK M. R., BONNER R. F., SMITH P. D., CHUAQUI R. F., ZHUANG Z., GOLDSTEIN S. R., WEISS R. A. and LIOTTA L. A. (1996): Laser capture microdissection. Science, 274, 998-1001.
30. FINK L., KOHLHOFF S., STEIN M. M., HANZE J., WEISSMANN N., ROSE F., AKKAYAGIL E., MANZ D., GRIMMINGER F., SEEGER W. and BOHLE R. M. (2002): cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am. J. Pathol., 160, 81-90.
31. GELMINI S., TRICARICO C., VONA G., LIVI L., MELINA A. D., SERNI S., CELLAI E., MAGRINI S., VILLARI D., CARINI M., SERIO M., FORTI G., PAZZAGLI M. and ORLANDO C. (2001): Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan detection system. Clin. Chem. Lab. Med., 39, 385-391.
32. GILLILAND G., PERRIN S., BLANCHARD K. and BUNN H. F. (1990): Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87, 2725-2729.
33. GINZINGER D. G. (2002): Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol., 30, 503-512.
34. GINZINGER D. G., GODFREY T. E., NIGRO J., MOORE D. H. 2nd, SUZUKI S., PALLAVICINI M. G., GRAY J. W. and JENSEN R. H. (2000): Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res., 60, 5405-5409.
35. GLOCKNER S., LEHMANN U., WILKE N., KLEEBERGER W., LANGER F. and KREIPE H. (2000): Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR. Pathobiology, 68, 173-179.
36. GOERKE C., BAYER M. G. and WOLZ C. (2001): Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and light cycler RT-PCR. Clin. Diagn. Lab. Immunol., 8, 279-282.
37. GOIDIN D., MAMESSIER A., STAQUET M. J., SCHMITT D. and BERTHIER-VERGNES O. (2001): Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and β-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal. Biochem., 295, 17-21.
38. GREBER-PLATZER S., SCHATZMANN-TURHANI D., WOLLENEK G. and LUBEC G. (1999): Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down syndrome. Biochem. Biophys. Res. Commun., 254, 395-399.
39. HALFORD W. P. (1999): The essential prerequisites for quantitative RT-PCR. Nat. Biotechnol., 17, 835.
40. HAMPTON R., WALKER M., MARSHALL J. and JUHL H. (2002): Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene, 21, 7817-7823.
41. HEID C. A., STEVENS J., LIVAK K. J. and WILLIAMS P. M. (1996): Real time quantitative PCR. Genome Res., 6, 986-994.
42. HEMPEL D. M., SMITH K. A., CLAUSSEN K. A. and PERRICONE M. A. (2002): Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR. J. Immunol. Methods, 259, 129-138.
43. HIGUCHI R., DOLLINGER G., WALSH P. S. and GRIFFITH R. (1992): Simultaneous amplification and detection of specific DNA sequences. Biotechnology (NY), 10, 413-417.
44. HOLLAND P. M., ABRAMSON R. D., WATSON R. and GELFAND D. H. (1991): Detection of specific polymerase chain reaction product by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA, 88, 7276-7280.
45. HOSLER G. A., BASH R. O., BAI X., JAIN V. and SCHEUERMANN R. H. (1999): Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am. J. Pathol., 154, 1023-1035.
46. HOUSSEAU F., LINDSEY K. R., OBERHOLTZER S. D., GONZALES M. I., BOUTIN P., MOORTHY A. K., SHANKARA S., ROBERTS B. L. and TOPALIAN S. L. (2002): Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients. J. Immunol. Methods, 266, 87-103.
47. IKEGUCHI M., UEDA T., SAKATANI T., HIROOKA Y. and KAIBARA N. (2002): Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn. Mol. Pathol., 11, 33-40.
48. ITO S., NAKANISHI H., HIRAI T., KATO T., KODERA Y., FENG Z., KASAI Y., ITO K., AKIYAMA S., NAKAO A. and TATEMATSU M. (2002): Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett., 183, 195-203.
49. JOHANSSON M., ARSTRAND K., HAKANSSON A., LINDHOLM C. and KAGEDAL B. (2000): Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction. Melanoma Res., 10, 213-222.
50. KAMMULA U. S., LEE K. H., RIKER A. I., WANG E., OHNMACHT G. A., ROSENBERG S. A. and MARINCOLA F. M. (1999): Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J. Immunol., 163, 6867-6875.
51. KAMMULA U. S., MARINCOLA F. M. and ROSENBERG S. A. (2000): Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination. J. Natl. Cancer Inst., 92, 1336-1344.
52. KARIYAZONO H., OHNO T., IHARA K., IGARASHI H., JOH-O K., ISHIKAWA S. and HARA T. (2001): Rapid detection of the 22q11.2 deletion with quantitative real-time PCR. Mol. Cell Probes, 15, 71-73.
53. KE L. D., CHEN Z. and YUNG W. K. (2000): A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol. Cell Probes, 14, 127-135.
54. KORNHUBER B., EBENER U., NIEGEMANN E. and WEHNER S. (1997): Minimal residual disease in leukemia in children. Ann. NY Acad. Sci., 824, 65-70.
55. KRAUTER J., HEIL G. and GANSER A. (2001): The AML1//MTG8 fusion transcript in t(8;21) positive AML and its implication for the detection of minimal residual disease; malignancy. Hematology, 5, 369-381.
56. LADETTO M., SAMETTI S., DONOVAN J. W., FERRERO D., ASTOLFI M., MITTERER M., RICCA I., DRANDI D., CORRADINI P., COSER P., PILERI A., GRIBBEN J. G. and TARELLA C. (2001): A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. Exp. Hematol., 29, 183-193.
57. LEE L. G., CONNELL C. R. and BLOCH W. (1993): Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res., 21, 3761-3766.
58. LEE P. P., YEE C., SAVAGE P. A., FONG L., BROCKSTEDT D., WEBER J. S., JOHNSON D., SWETTER S., THOMPSON J., GREENBERG P. D., ROEDERER M. and DAVIS M. M. (1999): Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med., 5, 677-685.
59. LUTHRA R., McBRIDE J. A., CABANILLAS F. and SARRIS A. (1998): Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32; q21) in patients with follicular lymphoma. Am. J. Pathol., 153, 63-68.
60. LUTHRA R., SARRIS A. H., HAI S., PALADUGU A. V., ROMAGUERA J. E., CABANILLAS F. F. and MEDEIROS L. J. (1999): Real-time 5′→3′ exonuclease-based PCR assay for detection of the t(11;14)(q 13; q32). Am. J. Clin. Pathol., 112, 524-530.
61. MARCUCCI G., LIVAK K. J., BI W., STROUT M. P., BLOOMFIELD C. D. and CALIGIURI M. A. (1998): Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia, 12, 1482-1489.
62. MAX N. and KEILHOLZ U. (2001): Minimal residual disease in melanoma. Semin. Surg. Oncol., 20, 319-328.
63. MAX N., WILLHAUCK M., WOLF K., THILO F., REINHOLD U., PAWLITA M., THIEL E. and KEILHOLZ U. (2001): Reliability of PCR-based detection of occult tumour cells: lessons from real-time RT-PCR. Melanoma Res., 11, 371-378.
64. MAX N., WOLF K., SPIKE B., THIEL E. and KEILHOLZ U. (2001): Nested quantitative real time PCR for detection of occult tumor cells. Recent Results Cancer Res., 158, 25-31.
65. MIFFLIN T. E., ESTEY C. A. and FELDER R. A. (2000): Robotic automation performs a nested RT-PCR analysis for HCV without introducing sample contamination. Clin. Chim. Acta, 290, 199-211.
66. MILD G., BACHMANN F., BOULAY J. L., GLATZ K., LAFFER U., LOWY A., METZGER U., REUTER J., TERRACCIANO L., HERRMANN R. and ROCHLITZ C. (2002): DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer. Int. J. Cancer, 102, 254-257.
67. MITAS M., MIKHITARIAN K., WALTERS C., BARON P. L., ELLIOTT B. M., BROTHERS T. E., ROBISON J. G., METCALF J. S., PALESCH Y. Y., ZHANG Z., GILLANDERS W. E. and COLE D. J. (2001): Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer, 93, 162-171.
68. MIYAZATO A., UENO S., OHMINE K., UEDA M., YOSHIDA K., YAMASHITA Y., KANEKO T., MORI M., KIRITO K., TOSHIMA M., NAKAMURA Y., SAITO K., KANO Y., FURUSAWA S., OZAWA K. and MANO H. (2001): Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood, 98, 422-427.
69. MOCELLIN S., OHNMACHT G. A., WANG E. and MARINCOLA F. M. (2001): Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness. Int. J. Cancer, 93, 236-242.
70. MOK S. C., CHAO J., SKATES S., WONG K., YIU G. K., MUTO M. G., BERKOWITZ R. S. and CRAMER D. W. (2001): Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J. Natl. Cancer Inst., 93, 1458-1464.
71. MONSURRO V., NIELSEN M. B., PEREZ-DIEZ A., DUDLEY M. E., WANG E., ROSENBERG S. A. and MARINCOLA F. M. (2001): Kinetics of TCR use in response to repeated epitope-specific immunization. J. Immunol., 166, 5817-5825.
72. MORTON D. L., WEN D. R., WONG J. H., ECONOMOU J. S., CAGLE L. A., STORM F. K., FOSHAG L. J. and COCHRAN A. J. (1992): Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg., 127, 392-399.
73. + T cells. J. Immunol., 165, 2287-2296.
74. NIGRO J. M., TAKAHASHI M. A., GINZINGER D. G., LAW M., PASSE S., JENKINS R. B. and ALDAPE K. (2001): Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am. J. Pathol., 158, 1253-1262.
75. OHNMACHT G. A., WANG E., MOCELLIN S., ABATI A., FILIE A., FETSCH P., RIKER A. I., KAMMULA U. S., ROSENBERG S. A. and MARINCOLA F. M. (2001): Short-term kinetics of tumor antigen expression in response to vaccination. J. Immunol., 167, 1809-1820.
76. OLIVER D. H., THOMPSON R. E., GRIFFIN C. A. and ESHLEMAN J. R. (2000): Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J. Mol. Diagn., 2, 202-208.
77. ORLANDO C., PINZANI P. and PAZZAGLI M. (1998): Developments in quantitative PCR. Clin. Chem. Lab. Med., 36, 255-269.
78. PANELLI M. C., WANG E., MONSURRO V. and MARINCOLA F. M. (2002): The role of quantitative PCR for the immune monitoring of cancer patients. Expert. Opin. Biol. Ther., 2, 537-544.
79. PONGERS-WILLEMSE M. J., VERHAGEN O. J., TIBBE G. J., WIJKHUUS A. J., DE HAAS V., ROOVERS E., VAN DER SCHOOT C. E. and VAN DONGEN J. J. (1998): Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia, 12, 2006-2014.
80. PREUDHOMME C., REVILLION F., MERLAT A., HORNEZ L., ROUMIER C., DUFLOS-GRARDEL N., JOUET J. P., COSSON A., PEYRAT J. P. and FENAUX P. (1999): Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a "real time" quantitative RT-PCR assay. Leukemia, 13, 957-964.
81. PROVENZANO M., MOCELLIN S., BETTINOTTI M., PREUSS J., MONSURRO V. V., MARINCOLA F. M. and STRONCEK D. (2002): Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-γ production by peptide-stimulated peripheral blood mononuclear cells. J. Immunother., 25, 342-351.
82. RAFF T., VAN DER GIET M., ENDEMANN D., WIEDERHOLT T. and PAUL M. (1997): Design and testing of β-actin primers for RT-PCR hat do not co-amplify processed pseudogenes. Biotechniques, 23, 45660.
83. RAJA S., EL-HEFNAWY T., KELLY L. A., CHESTNEY M. L., LUKETICH J. D. and GODFREY T. E. (2002): Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem., 48, 1329-1337.
84. REIMER T., HERRNRING C., KOCZAN D., RICHTER D., GERBER B., KABELITZ D., FRIESE K. and THIESEN H. J. (2000): FasL: Fas ratio - a prognostic factor in breast carcinomas. Cancer Res., 60, 822-828.
85. REIMER T., KOCZAN D., MULLER H., FRIESE K., THIESEN H. J. and GERBER B. (2002): Tumour Fas ligand: Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer. Breast Cancer Res., 4, R9.
86. REINHOLD U., BERKIN C., BOSSERHOFF A. K., DEUTSCHMANN A., GARBE C., GLASER R., HEIN R., KRAHN G., PETER R. U., RAPPL G., SCHITTEK B., SEITER S., UGUREL S., VOLKENANDT M. and TILGEN W. (2001): Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group. J. Clin. Oncol., 19, 1723-1727.
87. REIS P. P., ROGATTO S. R., KOWALSKI L. P., NISHIMOTO I. N., MONTOVANI J. C., CORPUS G., SQUIRE J. A. and KAMEL-REID S. (2002): Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene, 21, 6480-6487.
88. RICKMAN D. S., BOBEK M. P., MISEK D. E., KUICK R., BLAI VAS M., KURNIT D. M., TAYLOR J. and HANASH S. M. (2001): Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res., 61, 6885-6891.
89. SCHUTTEN M. and NIESTERS H. G. (2001): Clinical utility of viral quantification as a tool for disease monitoring. Expert. Rev. Mol. Diagn., 1, 153-162.
90. SCHWARZENBACH H. A. (2002): Diagnostic tool for monitoring multidrug resistance expression in human tumor tissues. Anal. Biochem., 308, 26-33.
91. SCHWEITZER B. and KINGSMORE S. (2001): Combining nucleic acid amplification and detection. Curr. Opin. Biotechnol., 12, 21-27.
92. SEEGER K., KREUZER K. A., LASS U., TAUBE T., BUCHWALD D., ECKERT C., KORNER G., SCHMIDT C. A. and HENZE G. (2001): Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. Cancer Res., 61, 2517-2522.
93. SELVEY S., THOMPSON E. W., MATTHAEI K., LEA R. A., IRVING M. G. and GRIFFITHS L. R. (2001): Beta-actin - an unsuitable internal control for RT-PCR. Mol. Cell Probes, 15, 307-311.
94. SERAZIN-LEROY V., DENIS-HENRIOT D., MOROT M., DE MAZANCOURT P. and GIUDICELLI Y. (1998): Semi-quantitative RT-PCR for comparison of mRNAs in cells with different amounts of housekeeping gene transcripts. Mol. Cell Probes, 12, 283-291.
95. SOLANAS M., MORAL R. and ESCRICH E. (2001): Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Anal. Biochem., 288, 99-102.
96. SOONG R., BEYSER K., BASTEN O., KALBE A., RUESCHOFF J. and TABITI K. (2001): Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin. Cancer Res., 7, 3423-3429.
97. SPECHT K., RICHTER T., MULLER U., WALCH A., WERNER M. and HOFLER H. (2001): Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am. J. Pathol., 158, 419-429.
98. SPECTOR S. A., WONG R., HSIA K., PILCHER M. and STEMPIEN M. J. (1998): Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest., 101, 497-502.
99. STEUERWALD N., COHEN J., HERRERA R. J. and BRENNER C. A. (2000): Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol. Hum. Reprod., 6, 448-453.
100. STORDEUR P., POULIN L. F., CRACIUN L., ZHOU L., SCHANDENE L., DE LAVAREILLE A., GORIELY S. and GOLDMAN M. (2002): Cytokine mRNA quantification by real-time PCR. J. Immunol. Methods, 259, 55-64.
101. STRAUB B., MULLER M., KRAUSE H., SCHRADER M., GOESSL C., HEICAPPELL R. and MILLER K. (2001): Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction. Urology, 58, 815-820.
102. SUGIYAMA Y., SUGIYAMA K., HIRAI Y., AKIYAMA F. and HASUMI K. (2002): Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am. J. Clin. Pathol., 117, 109-116.
103. SUMMERS K. E., GOFF L. K., WILSON A. G., GUPTA R. K., LISTER T. A. and FITZGIBBON J. (2001): Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J. Clin. Oncol., 19, 420-424.
104. SUZUKI S., MOORE D. H. 2nd, GINZINGER D. G., GODFREY T. E., BARCLAY J., POWELL B., PINKEL D., ZALOUDEK C., LU K., MILLS G., BERCHUCK A. and GRAY J. W. (2000): An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res., 60, 5382-5385.
105. SUZUKI T., HIGGINS P. J. and CRAWFORD D. R. (2000): Control selection for RNA quantitation. Biotechniques, 29, 332-337.
106. TEDESCHI R., ENBOM M., BIDOLI E., LINDE A., DE PAOLI P. and DILLNER J. (2001): Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J. Clin. Microbiol., 39, 4269-4273.
107. TSAO H., NADIMINTI U., SOBER A. J. and BIGBY M. (2001): A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch. Dermatol., 137, 325-330.
108. VAN TRAPPEN P. O., GYSELMAN V. G., LOWE D. G., RYAN A., ORAM D. H., BOSZE P., WEEKES A. R., SHEPHERD J. H., DORUDI S., BUSTIN S. A. and JACOBS I. J. (2001): Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet, 357, 15-20.
109. VELCULESCU V. E., ZHANG L., VOGELSTEIN B. and KINZLER K. W. (1995): Serial analysis of gene expression. Science, 270, 484-487.
110. VERHAGEN O. J., WILLEMSE M. J., BREUNIS W. B., WIJKHUIJS A. J., JACOBS D. C., JOOSTEN S. A., VAN WERING E. R., VAN DONGEN J. J. and VAN DER SCHOOT C. E. (2000): Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia, 14, 1426-1435.
111. WALCH A., SPECHT K., SMIDA J., AUBELE M., ZITZELSBERGER H., HOFLER H. and WERNER M. (2001): Tissue microdissection techniques in quantitative genome and gene expression analyses. Histochem. Cell Biol., 115, 269-276.
112. WALL S. J. and EDWARDS D. R. (2002): Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs. Anal. Biochem., 300, 269-273.
113. WANG E. and MARINCOLA F. M. (2000): A natural history of melanoma: serial gene expression analysis. Immunol. Today, 21, 619-623.
114. WANG E., MILLER L. D., OHNMACHT G. A., LIU E. T. and MARINCOLA F. M. (2000): High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol., 18, 457-459.
115. WANG E., MILLER L. D., OHNMACHT G. A., MOCELLIN S., PEREZ-DIEZ A., PETERSEN D., ZHAO Y., SIMON R., POWELL J. I., ASAKI E., ALEXANDER H. R., DURAY P. H., HERLYN M., RESTIFO N. P., LIU E. T., ROSENBERG S. A. and MARINCOLA F. M. (2002): Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res., 62, 3581-3586.
116. WILLEY J. C., CRAWFORD E. L., JACKSON C. M., WEAVER D. A., HOBAN J. C., KHUDER S. A. and DEMUTH J. P. (1998): Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am. J. Respir. Cell Mol. Biol., 19, 6-17.
117. XIE D., NAKACHI K., WANG H., ELASHOFF R. and KOEFFLER H. P. (2001): Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res., 61, 8917-8923.
118. ZHANG T., HILLION J., TONG J. H., CAO Q., CHEN S. J., BERGER R. and CHEN Z. (1994): AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia, 8, 729-734.
119. ZHONG H. and SIMONS J. W. (1999): Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun., 259, 523-526.
120. ZHU G., CHANG Y., ZUO J., Dong X., ZHANG M., HU G. and FANG F. (2001): Fudenine, a C-terminal truncated rat homologue of mouse prominin, is blood glucose-regulated and can up-regulate the expression of GAPDH. Biochem. Biophys. Res. Commun., 281, 951-956.